Metabolic signatures linked to macrophage polarization: From glucose metabolism to oxidative phosphorylation

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 740-744

  Boscá, Lisardo ^a,b   González Ramos, Silvia ^a   Prieto, Patricia ^a   Fernández Velasco, María ^a   Mojena, Marina ^a   Martín Sanz, Paloma ^a,b   Alemany, Susana ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Glycolysis; Inflammation; Inhibitors; Isoenzyme; Macrophage; Metabolism

Indexed keywords

GLUCOSE; GLYCOLYTIC ENZYME;

ARTICLE; BIOSYNTHESIS; CELL FATE; ENERGY METABOLISM; GLUCOSE METABOLISM; HUMAN; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; METABOLIC ACTIVATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; IMMUNOLOGY; MACROPHAGE; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION;

ENERGY METABOLISM; GLUCOSE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; OXIDATION-REDUCTION; PHOSPHORYLATION;

EID: 84938772588     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150107     Document Type: Article

References (45)

1. Robbins, C.S., Hilgendorf, I., Weber, G.F., Theurl, I., Iwamoto, Y., Figueiredo, J.L., Gorbatov, R., Sukhova, G.K., Gerhardt, L.M., Smyth, D. et al. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166-1172 CrossRef PubMed
2. Davies, L.C., Jenkins, S.J., Allen, J.E. and Taylor, P.R. (2013) Tissue-resident macrophages. Nat. Immunol. 14, 986-995 CrossRef PubMed
3. Varol, C., Mildner, A. and Jung, S. (2015) Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33, 643-675 CrossRef PubMed
4. Fernandez-Velasco, M., Gonzalez-Ramos, S. and Bosca, L. (2014) Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases. Biochem. J. 458, 187-193 CrossRef PubMed
5. Gordon, S. and Martinez, F.O. (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604 CrossRef PubMed
6. Mantovani, A. (2010) Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 10, 369-373 CrossRef PubMed
7. Rodriguez-Prados, J.C., Traves, P.G., Cuenca, J., Rico, D., Aragones, J., Martin-Sanz, P., Cascante, M. and Bosca, L. (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185, 605-614 CrossRef PubMed
8. Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A.S., Johnson, R.S. and Nizet, V. (2007) Cutting edge: Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516-7519 CrossRef PubMed
9. Tawakol, A., Singh, P., Mojena, M., Pimentel-Santillana, M., Emami, H., MacNabb, M., Rudd, J.H., Narula, J., Enriquez, J.A., Traves, P.G. et al. (2015) HIF-1α and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages. Arterioscler Thromb. Vasc. Biol., in the press
10. Bosca, L., Zeini, M., Traves, P.G. and Hortelano, S. (2005) Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 208, 249-258 CrossRef PubMed
11. Rico, D., Vaquerizas, J.M., Dopazo, H. and Bosca, L. (2007) Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences. BMC Genomics 8, 271 CrossRef PubMed
12. Palsson-McDermott, E.M., Curtis, A.M., Goel, G., Lauterbach, M.A., Sheedy, F.J., Gleeson, L.E., van den Bosch, M.W., Quinn, S.R., Domingo-Fernandez, R., Johnston, D.G. et al. (2015) Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21, 65-80 CrossRef PubMed
13. Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M.T., Billiar, T.R., Wang, H., Cao, L. and Tang, D. (2014) PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 PubMed
14. Gordon, S., Pasare, C. and Medzhitov, R. (2007) The macrophage: past, present and future. Toll-like receptors: linking innate and adaptive immunity. Eur. J. Immunol. 37, S9-S17 CrossRef PubMed
15. Martinez, F.O., Gordon, S., Locati, M. and Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311 CrossRef PubMed
16. Odegaard, J.I., Ricardo-Gonzalez, R.R., Red Eagle, A., Vats, D., Morel, C.R., Goforth, M.H., Subramanian, V., Mukundan, L., Ferrante, A.W. and Chawla, A. (2008) Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507 CrossRef PubMed
17. Olefsky, J.M. and Glass, C.K. (2010) Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246 CrossRef PubMed
18. Al-Lahham, S., Roelofsen, H., Rezaee, F., Weening, D., Hoek, A., Vonk, R. and Venema, K. (2012) Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur. J. Clin. Invest. 42, 357-364 CrossRef PubMed
19. Prieto, P., Cuenca, J., Traves, P.G., Fernandez-Velasco, M., Martin-Sanz, P. and Bosca, L. (2010) Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ. 17, 1179-1188 CrossRef PubMed
20. Folco, E.J., Sheikine, Y., Rocha, V.Z., Christen, T., Shvartz, E., Sukhova, G.K., Di Carli, M.F. and Libby, P. (2011) Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18F-labeled 2-deoxy-D-glucose positron emission tomography. J. Am. Coll. Cardiol. 58, 603-614 CrossRef PubMed
21. Hahn, E.L., Halestrap, A.P. and Gamelli, R.L. (2000) Expression of the lactate transporter MCT1 in macrophages. Shock 13, 253-260 CrossRef PubMed
22. Moreira, T.J., Pierre, K., Maekawa, F., Repond, C., Cebere, A., Liljequist, S. and Pellerin, L. (2009) Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells. J. Cereb. Blood Flow Metab. 29, 1273-1283 CrossRef PubMed
23. Lazo, P.A. and Bosca, L. (1982) Mitochondrial membrane-bound hexokinase of ascites tumor cells. Functional implications of lysine residues studied by modification with imidoesters. Hoppe Seylers Z. Physiol. Chem. 363, 635-641 CrossRef PubMed
24. Tahara, N., Mukherjee, J., de Haas, H.J., Petrov, A.D., Tawakol, A., Haider, N., Tahara, A., Constantinescu, C.C., Zhou, J., Boersma, H.H. et al. (2014) 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat. Med. 20, 215-219 CrossRef PubMed
25. Sols, A. and Crane, R.K. (1954) Substrate specificity of brain hexokinase. J. Biol. Chem. 210, 581-595 PubMed
26. Rider, M.H., Bertrand, L., Vertommen, D., Michels, P.A., Rousseau, G.G. and Hue, L. (2004) 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381, 561-579 CrossRef PubMed
27. Bosca, L., Aragon, J.J. and Sols, A. (1985) Modulation of muscle phosphofructokinase at physiological concentration of enzyme. J. Biol. Chem. 260, 2100-2107 PubMed
28. Bando, H., Atsumi, T., Nishio, T., Niwa, H., Mishima, S., Shimizu, C., Yoshioka, N., Bucala, R. and Koike, T. (2005) Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin. Cancer Res. 11, 5784-5792 CrossRef PubMed
29. Fukasawa, M., Tsuchiya, T., Takayama, E., Shinomiya, N., Uyeda, K., Sakakibara, R. and Seki, S. (2004) Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J. Biochem. 136, 273-277 CrossRef PubMed
30. Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M.A., Arumugam, S., Dean, W.L., Eaton, J. et al. (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol. Cancer Ther. 7, 110-120 CrossRef PubMed
31. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B.W., Cantelmo, A.R., Quaegebeur, A., Ghesquiere, B., Cauwenberghs, S., Eelen, G. et al. (2013) Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651-663 CrossRef PubMed
32. Eltzschig, H.K. and Carmeliet, P. (2011) Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665 CrossRef PubMed
33. Kawaguchi, T., Veech, R.L. and Uyeda, K. (2001) Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. J. Biol. Chem. 276, 28554-28561 CrossRef PubMed
34. Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V. and Caro, J. (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J. Biol. Chem. 277, 6183-6187 CrossRef PubMed
35. Obach, M., Navarro-Sabate, A., Caro, J., Kong, X., Duran, J., Gomez, M., Perales, J.C., Ventura, F., Rosa, J.L. and Bartrons, R. (2004) 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J. Biol. Chem. 279, 53562-53570 CrossRef PubMed
36. Telang, S., Yalcin, A., Clem, A.L., Bucala, R., Lane, A.N., Eaton, J.W. and Chesney, J. (2006) Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 25, 7225-7234 CrossRef PubMed
37. Anastasiou, D., Yu, Y., Israelsen, W.J., Jiang, J.K., Boxer, M.B., Hong, B.S., Tempel, W., Dimov, S., Shen, M., Jha, A. et al. (2012) Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8, 839-847 CrossRef PubMed
38. Chaneton, B. and Gottlieb, E. (2012) Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. Trends Biochem. Sci. 37, 309-316 CrossRef PubMed
39. Cortes-Cros, M., Hemmerlin, C., Ferretti, S., Zhang, J., Gounarides, J.S., Yin, H., Muller, A., Haberkorn, A., Chene, P., Sellers, W.R. and Hofmann, F. (2013) M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc. Natl. Acad. Sci. U.S.A. 110, 489-494 CrossRef PubMed
40. Mulukutla, B.C., Khan, S., Lange, A. and Hu, W.S. (2010) Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. Trends Biotechnol. 28, 476-484 CrossRef PubMed
41. Chaneton, B., Hillmann, P., Zheng, L., Martin, A.C., Maddocks, O.D., Chokkathukalam, A., Coyle, J.E., Jankevics, A., Holding, F.P., Vousden, K.H. et al. (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491, 458-462 CrossRef PubMed
42. Israelsen, W.J., Dayton, T.L., Davidson, S.M., Fiske, B.P., Hosios, A.M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J.W. et al. (2013) PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155, 397-409 CrossRef PubMed
43. Keller, K.E., Doctor, Z.M., Dwyer, Z.W. and Lee, Y.S. (2014) SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol. Cell. 53, 700-709 CrossRef PubMed
44. Traves, P.G., de Atauri, P., Marin, S., Pimentel-Santillana, M., Rodriguez-Prados, J.C., Marin de Mas, I., Selivanov, V.A., Martin-Sanz, P., Bosca, L. and Cascante, M. (2012) Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach. J. Immunol. 188, 1402-1410 CrossRef PubMed
45. Newsholme, P. and Newsholme, E.A. (1989) Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem. J. 261, 211-218 PubMed